Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Novarad Updates NovaPACS EI Customers Worldwide to 9.1, a Major Security Upgrade

August 27, 2026

Busy Philipps diagnosed with rare brain tumour: ‘Grateful that I’m alive’

August 27, 2026

Alurion Launches Amargosa PFS Program to Advance a Scalable Atlantic-Basin Bauxite Project

August 27, 2026

Petition to rename Nashville airport in honour of Dolly Parton gains traction

August 27, 2026

Google’s AI note-taking app now allows you to interact with books

August 27, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Truveta deepens health system leadership with appointment of Erik Wexler to Board of Directors
Press Release

Truveta deepens health system leadership with appointment of Erik Wexler to Board of Directors

By News RoomMarch 31, 20263 Mins Read
Truveta deepens health system leadership with appointment of Erik Wexler to Board of Directors
Share
Facebook Twitter LinkedIn Pinterest Email

BELLEVUE, Wash., March 31, 2026 (GLOBE NEWSWIRE) — Grounded in its mission of Saving Lives with Data, Truveta today announced the appointment of Erik Wexler, President and CEO of Providence, to its Board of Directors, representing Providence—one of Truveta’s founding health system members.

Wexler succeeds Rod Hochman, MD, former President and CEO of Providence, who has served as Truveta Board Chair since 2024 and played a foundational role in the company’s formation and early growth. His appointment ensures continued leadership and partnership from Providence as Truveta expands its impact across healthcare, life sciences, government, and research.

This announcement follows Truveta’s recent Board leadership transition, including the appointment of Robin Damschroder, FACHE, as Chair of the Board of Directors, reflecting the company’s continued focus on health system-led governance and long-term value creation.

“Erik is a respected leader with a deep commitment to improving health and advancing innovation across care delivery,” said Terry Myerson, CEO and Co-founder of Truveta. “His experience leading one of the nation’s largest health systems, combined with a clear focus on patients and communities, will be invaluable as Truveta continues to grow and deliver on its mission of Saving Lives with Data.”

Wexler brings extensive experience in health system leadership, operations, and strategy, with a track record of driving performance, expanding access to care, and advancing digital and data-driven transformation. As President and CEO of Providence, he leads a comprehensive health system serving communities across the western United States.

“I’m honored to join the Truveta Board and represent Providence in this important work,” said Wexler. “Truveta’s unique model—bringing health systems, life sciences, government, and academia together to improve care—has the potential to transform how we care for all patients. I look forward to contributing to this mission and helping ensure we continue to deliver meaningful impact for the communities we serve.”

Wexler’s appointment reflects Truveta’s continued commitment to health-system-led governance and strong alignment with its member organizations as it advances trusted, regulatory-grade evidence and accelerates innovation in clinical research.

About Truveta

Truveta provides unprecedented real-world data and real-time intelligence, powered by a dataset built with and owned by U.S. health systems united in a mission of Saving Lives with Data. Together, we power breakthrough discoveries, accelerate regulatory-grade evidence, and improve patient care.

Truveta membership includes Providence, Advocate Health, Trinity Health, Tenet Healthcare, Northwell Health, AdventHealth, Baptist Health of Northeast Florida, Baylor Scott & White Health, Bon Secours Mercy Health, CommonSpirit Health, Hawaii Pacific Health, HealthPartners, Henry Ford Health System, HonorHealth, Inova, Lehigh Valley Health Network, MedStar Health, Memorial Hermann Health System, MetroHealth, Novant Health, Ochsner Health, Premier Health, Saint Luke’s Health System, Sanford Health, Sentara Healthcare, Texas Health Resources, TriHealth, UnityPoint Health, Virtua Health, and WellSpan Health.

  • Truveta today announced the appointment of Erik Wexler, President and CEO of Providence, to its Board of Directors, representing Providence—one of Truveta’s founding health system members.
            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Novarad Updates NovaPACS EI Customers Worldwide to 9.1, a Major Security Upgrade

Alurion Launches Amargosa PFS Program to Advance a Scalable Atlantic-Basin Bauxite Project

Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

Troutman Amin, LLP Elevates Former Prosecutor Tori L. Guidry to Partner in Complex Litigation Group

Levanta Raises $22M Series B from Volition Capital to Deploy the Infrastructure for Creator Commerce Media

Defiance Launches PRAM, the First U.S.-Listed ETF to Combine Memory and Photonics*

NFWF Announces Nearly $2.4 Million in Grants from the Grassland Resilience and Conservation Initiative

Ammobia and Lummus Technology to Commercialize Ammonia for Low-Carbon Energy

Zoomex Launches TradFi Zone Upgrade With 80% Fee Discount Early Bird Campaign

Editors Picks

Busy Philipps diagnosed with rare brain tumour: ‘Grateful that I’m alive’

August 27, 2026

Alurion Launches Amargosa PFS Program to Advance a Scalable Atlantic-Basin Bauxite Project

August 27, 2026

Petition to rename Nashville airport in honour of Dolly Parton gains traction

August 27, 2026

Google’s AI note-taking app now allows you to interact with books

August 27, 2026

Latest News

Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

August 27, 2026

Troutman Amin, LLP Elevates Former Prosecutor Tori L. Guidry to Partner in Complex Litigation Group

August 27, 2026

Levanta Raises $22M Series B from Volition Capital to Deploy the Infrastructure for Creator Commerce Media

August 27, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version